Cargando…
Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells
Wu-Mei-Wan (WMW) is a Chinese herbal formula used to treat type 2 diabetes. In this study, we aimed to explore the effects and mechanisms of WMW on insulin resistance in HepG2 cells. HepG2 cells were pretreated with palmitate (0.25 mM) to impair the insulin signaling pathway. Then, they were treated...
Autores principales: | Yang, Xueping, Li, Lingli, Fang, Ke, Dong, Ruolan, Li, Jingbin, Zhao, Yan, Dong, Hui, Yi, Ping, Huang, Zhaoyi, Chen, Guang, Lu, Fuer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591966/ https://www.ncbi.nlm.nih.gov/pubmed/28928791 http://dx.doi.org/10.1155/2017/7283241 |
Ejemplares similares
-
Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
por: Yang, Xueping, et al.
Publicado: (2019) -
Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation
por: Wu, Fan, et al.
Publicado: (2021) -
Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization
por: Yan, Shuguang, et al.
Publicado: (2022) -
Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats
por: Chen, Guang, et al.
Publicado: (2017) -
Jiao Tai Wan Attenuates Hepatic Lipid Accumulation in Type 2 Diabetes Mellitus
por: Huang, Zhaoyi, et al.
Publicado: (2013)